VSTM logo

Verastem, Inc. (VSTM)

Profile

Full Name

Verastem, Inc.

Ticker

NASDAQ: VSTM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 27, 2012

Indexes

Not included

Website

https://www.verastem.com

Employees

78

Key Details

Price

$9.61(1.91%)

Market Cap

$723.82M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$10.00M(100.00% YoY)

Annual EPS

-$3.66(7.66% YoY)

PE Ratio

-

Next earnings date

Mar 19, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $9.61
    VSTM price is $9.61

    30-Day Relative Volume

    0.68
    VSTM 30-day relative volume is 0.68

    Price Performance

    Price Most Recent Change

    +1.91%
    VSTM price was up +1.91% on Dec 12, 2025

    Price YTD Change

    +85.88%
    VSTM price is up +85.88% since January 1st

    Price 1-Year Change

    +113.56%
    VSTM price is up +113.56% year-on-year

    Price 3-Year Change

    +66.84%
    VSTM price is up +66.84% over the past 3 years

    Price Range

    Price All-Time High

    $225.84
    VSTM price is currently -95.74% below its historical high of $225.84

    Price 3-Year Low

    $2.10
    VSTM price is currently +357.62% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $723.82M
    VSTM market cap is $723.82 million

    Market Cap 3-Year Change

    +653.64%
    VSTM market cap is up +653.64% over the past 3 years

    Market Cap All-Time High

    $833.81M
    VSTM market cap is currently -13.19% below its historical high of $833.81 million

    Market Cap Sector Percentile

    66.36%
    VSTM market cap is higher than 66.36% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +69.23%
    VSTM shares outstanding is up +69.23% year-on-year

    Shares Outstanding 3-Year Change

    +351.71%
    VSTM shares outstanding is up +351.71% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.25
    VSTM beta is 1.25

    200-day SMA

    $7.43
    VSTM price is currently +29.42% above its 200-day simple moving average

    50-day SMA

    $9.13
    VSTM price is currently +5.27% above its 50-day simple moving average

    14-Day RSI

    49.73
    VSTM 14-day relative strength index is 49.73

    Volume

    0.68
    VSTM 30-day relative volume is 0.68

    ATR

    $0.62
    VSTM average true range is $0.62

    10-day Historical Volatility

    55.85%
    VSTM 10-day historical volatility is 55.85%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $10.00M
    VSTM annual revenue is $10.00 million

    Revenue Analysts Estimate

    $30.78M
    VSTM annual revenue is currently -67.51% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +100%
    VSTM annual revenue is up +100% year-on-year

    Revenue Sector Percentile

    48.29%
    VSTM annual revenue is higher than 48.29% of companies in Healthcare sector

    EPS

    EPS

    -$3.66
    VSTM annual earnings per share is -$3.66

    EPS Analysts Estimate

    -$2.73
    VSTM annual earnings per share is currently -34.24% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +7.66%
    VSTM annual earnings per share is up +7.66% year-on-year

    EPS Sector Percentile

    26.72%
    VSTM annual earnings per share is higher than 26.72% of companies in Healthcare sector

    Profit

    Gross Profit

    $9.97M
    VSTM annual gross profit is $9.97 million

    Gross Margin

    99.74%
    VSTM annual gross profit margin is 99.74%

    Operating Profit

    -$114.96M
    VSTM annual operating income is -$114.96 million

    Operating Margin

    -1149.56%
    VSTM annual operating profit margin is -1149.56%

    Net Income

    -$130.64M
    VSTM annual net profit is -$130.64 million

    Net Margin

    -1306.37%
    VSTM annual net profit margin is -1306.37%

    Expenses

    Total Expenses

    $140.64M
    VSTM annual total expenses is $140.64 million

    Operating Expenses

    $124.93M
    VSTM annual total operating expenses is $124.93 million

    Cost Of Goods Sold

    $26.00K
    VSTM annual cost of goods sold is $26.00 thousand

    Selling, General & Administrative Expenses

    $0.00
    VSTM annual SG&A is $0.00

    Depreciation & Amortization

    $26.00K
    VSTM annual D&A is $26.00 thousand

    Interest Expense

    $0.00
    VSTM annual interest expense is $0.00

    Income Tax

    $185.00K
    VSTM annual income tax is $185.00 thousand

    EBIT & EBITDA

    EBIT

    -$114.96M
    VSTM annual earnings before interest & taxes is -$114.96 million

    EBITDA

    -$114.93M
    VSTM annual EBITDA is -$114.93 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $101.54M
    VSTM annual total assets is $101.54 million

    Non Current Assets

    $6.58M
    VSTM annual long term assets is $6.58 million

    Current Assets

    $94.96M
    VSTM annual total current assets is $94.96 million

    Cash and Cash Equivalents

    $88.82M
    VSTM annual cash & cash equivalents is $88.82 million

    Accounts Receivable

    -
    VSTM annual accounts receivable value is unknown

    Inventory

    $0.00
    VSTM annual inventory is $0.00

    Liabilities

    Total Liabilities

    $130.43M
    VSTM annual total liabilities is $130.43 million

    Long Term Liabilities

    $99.46M
    VSTM annual total long term liabilities is $99.46 million

    Current Liabilities

    $30.97M
    VSTM annual current liabilities is $30.97 million

    Accounts Payable

    $4.03M
    VSTM annual accounts payable is $4.03 million

    Debt

    Total Debt

    $42.25M
    VSTM annual total debt is $42.25 million

    Total Debt 1-Year Change

    +1.68%
    VSTM annual total debt is up +1.68% year-on-year

    Long Term Debt

    $41.26M
    VSTM annual long term debt is $41.26 million

    Short Term Debt

    $995.00K
    VSTM annual short term debt is $995.00 thousand

    Equity & Capital

    Shareholders Equity

    -$28.89M
    VSTM annual stockholders equity is -$28.89 million

    Book Value

    -$28.89M
    VSTM annual book value is -$28.89 million

    Retained Earnings

    -$955.53M
    VSTM annual retained earnings is -$955.53 million

    Working Capital

    $63.99M
    VSTM annual working capital is $63.99 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$104.77M
    VSTM annual cash from operations is -$104.77 million

    Cash From Operations 1-Year Change

    -21.18%
    VSTM annual cash from operations is down -21.18% year-on-year

    Cash From Investing

    $59.97M
    VSTM annual cash from investing is $59.97 million

    Cash From Investing 1-Year Change

    +234.93%
    VSTM annual cash from investing is up +234.93% year-on-year

    Cash From Financing

    $54.78M
    VSTM annual cash from financing is $54.78 million

    Cash From Financing 1-Year Change

    -59.18%
    VSTM annual cash from financing is down -59.18% year-on-year

    CAPEX

    CAPEX

    $28.00K
    VSTM annual capital expenditures is $28.00 thousand

    CAPEX 1-Year Change

    +100%
    VSTM annual capital expenditures is up +100% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$104.80M
    VSTM annual free cash flow is -$104.80 million

    Free Cash Flow 1-Year Change

    -21.21%
    VSTM annual free cash flow is down -21.21% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    99.74%
    VSTM annual gross profit margin is 99.74%

    Operating Margin

    -1149.56%
    VSTM annual operating profit margin is -1149.56%

    Net Margin

    -1306.37%
    VSTM annual net profit margin is -1306.37%

    ROA & ROE

    ROA

    -103.99%
    VSTM annual return on assets is -103.99%

    ROE

    -526.34%
    VSTM annual return on equity is -526.34%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    VSTM price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    VSTM price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -46.62
    VSTM price to book ratio is -46.62

    PB Ratio Sector Percentile

    1.5%
    VSTM price to book ratio is higher than 1.5% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    54.10
    VSTM price to sales ratio is 54.10

    PS Ratio Sector Percentile

    86.56%
    VSTM price to sales ratio is higher than 86.56% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $675.59M
    VSTM enterprise value is $675.59 million

    Enterprise Value Sector Percentile

    66.64%
    VSTM enterprise value is higher than 66.64% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -4.23
    VSTM EV/EBITDA is -4.23

    EV/EBITDA Sector Percentile

    27.57%
    VSTM EV/EBITDA is higher than 27.57% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    3.07
    VSTM annual current ratio is 3.07

    Quick Ratio

    3.07
    VSTM annual quick ratio is 3.07

    Leverage

    Debt To Equity

    -1.46
    VSTM annual debt to equity ratio is -1.46

    Interest Coverage Ratio

    -
    VSTM annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    VSTM piotroski f-score value is unknown

    Altman Z-Score

    -12.73
    VSTM altman z-score is -12.73

    Analyst ratings

    Recent major analysts updates

    Sep 9, 25 BTIG
    Buy
    Aug 8, 25 RBC Capital
    Outperform
    Jun 25, 25 RBC Capital
    Outperform
    May 9, 25 HC Wainwright & Co.
    Buy
    Apr 10, 25 Jefferies
    Buy
    Apr 9, 25 Mizuho
    Outperform
    Mar 24, 25 HC Wainwright & Co.
    Buy
    Mar 24, 25 Guggenheim
    Buy
    Mar 21, 25 RBC Capital
    Outperform
    Jan 31, 25 B. Riley Securities
    Buy

    Institutional Ownership

    Screeners with VSTM included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Verastem, Inc.?
    • Does Verastem, Inc. pay dividends?
    • What sector is Verastem, Inc. in?
    • What industry is Verastem, Inc. in?
    • What country is Verastem, Inc. based in?
    • When did Verastem, Inc. go public?
    • Is Verastem, Inc. in the S&P 500?
    • Is Verastem, Inc. in the NASDAQ 100?
    • Is Verastem, Inc. in the Dow Jones?
    • When was Verastem, Inc.'s last earnings report?
    • When does Verastem, Inc. report earnings?

    What is the ticker symbol for Verastem, Inc.?

    The ticker symbol for Verastem, Inc. is NASDAQ:VSTM

    Does Verastem, Inc. pay dividends?

    No, Verastem, Inc. does not pay dividends

    What sector is Verastem, Inc. in?

    Verastem, Inc. is in the Healthcare sector

    What industry is Verastem, Inc. in?

    Verastem, Inc. is in the Biotechnology industry

    What country is Verastem, Inc. based in?

    Verastem, Inc. is headquartered in United States

    When did Verastem, Inc. go public?

    Verastem, Inc.'s initial public offering (IPO) was on January 27, 2012

    Is Verastem, Inc. in the S&P 500?

    No, Verastem, Inc. is not included in the S&P 500 index

    Is Verastem, Inc. in the NASDAQ 100?

    No, Verastem, Inc. is not included in the NASDAQ 100 index

    Is Verastem, Inc. in the Dow Jones?

    No, Verastem, Inc. is not included in the Dow Jones index

    When was Verastem, Inc.'s last earnings report?

    Verastem, Inc.'s most recent earnings report was on November 4, 2025

    When does Verastem, Inc. report earnings?

    The next expected earnings date for Verastem, Inc. is March 19, 2026
    On this page